APO Research
Talk to an analyst

APO RESEARCH · REPORT

Candida Infection Testing

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Candida Infection Testing Industry Growth and Trends Forecast to 2032

2 May 2026121 pages

Choose your research edition.

Industry ResearchCandida Infection Testing Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Candida Infection Testing Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Candida Infection Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Candida Infection Testing Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Candida Infection Testing Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

According to APO Research, the global Candida Infection Testing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Candida Infection Testing is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Candida Infection Testing is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Candida Infection Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Candida Infection Testing market include Roche Diagnostics, Abbott Diagnostics, bioMérieux, Becton Dickinson, Thermo Fisher Scientific, Siemens Healthineers, Bruker, Danaher and QuidelOrtho, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Candida Infection Testing market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Candida Infection Testing market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Candida Infection Testing market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Candida Infection Testing.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Candida Infection Testing market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Candida Infection Testing Market by Company

Roche Diagnostics

Abbott Diagnostics

bioMérieux

Becton Dickinson

Thermo Fisher Scientific

Siemens Healthineers

Bruker

Danaher

QuidelOrtho

Luminex

Hologic

Sysmex

Bio‑Rad Laboratories

Cepheid

Qiagen

ARUP Laboratories

Labcorp

Quest Diagnostics

Eurofins Scientific

Synlab

Candida Infection Testing Segment by Type

Traditional Culture

Molecular Biology Detection

Candida Infection Testing Segment by Application

Medical

Maternal and Child Health

Physical Examination

Aesthetic Medicine

Other

Candida Infection Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Candida Infection Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Candida Infection Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Candida Infection Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Candida Infection Testing companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Candida Infection Testing Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Candida Infection Testing Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Candida Infection Testing Market Share by Region (2021-2026) Table 4. Global Candida Infection Testing Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Candida Infection Testing Market Share by Region (2027-2032) Table 6. Global Candida Infection Testing Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Candida Infection Testing Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Candida Infection Testing Market Size Share by Type (2021-2026) Table 9. Global Candida Infection Testing Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Candida Infection Testing Market Size Share Forecasted by Type (2027-2032) Table 11. North America Candida Infection Testing Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Candida Infection Testing Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Candida Infection Testing Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Candida Infection Testing Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Candida Infection Testing Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Candida Infection Testing Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Candida Infection Testing Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Candida Infection Testing Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Candida Infection Testing Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Candida Infection Testing Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Candida Infection Testing Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Candida Infection Testing Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Candida Infection Testing Market Size Share by Application (2021-2026) Table 24. Global Candida Infection Testing Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Candida Infection Testing Market Size Share Forecasted by Application (2027-2032) Table 26. North America Candida Infection Testing Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Candida Infection Testing Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Candida Infection Testing Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Candida Infection Testing Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Candida Infection Testing Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Candida Infection Testing Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Candida Infection Testing Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Candida Infection Testing Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Candida Infection Testing Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Candida Infection Testing Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Candida Infection Testing Industry Trends Table 37. Candida Infection Testing Industry Drivers Table 38. Candida Infection Testing Industry Opportunities and Challenges Table 39. Candida Infection Testing Industry Restraints Table 40. Global Candida Infection Testing Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Candida Infection Testing Revenue Market Share by Company (2021-2026) Table 42. Global Candida Infection Testing Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Candida Infection Testing Key Company Headquarters & Area Served Table 44. Global Candida Infection Testing Company, Product Type & Application Table 45. Global Candida Infection Testing Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Candida Infection Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Roche Diagnostics Company Information Table 49. Roche Diagnostics Business Overview Table 50. Roche Diagnostics Candida Infection Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Roche Diagnostics Candida Infection Testing Product Portfolio Table 52. Roche Diagnostics Recent Development Table 53. Abbott Diagnostics Company Information Table 54. Abbott Diagnostics Business Overview Table 55. Abbott Diagnostics Candida Infection Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Abbott Diagnostics Candida Infection Testing Product Portfolio Table 57. Abbott Diagnostics Recent Development Table 58. bioMérieux Company Information Table 59. bioMérieux Business Overview Table 60. bioMérieux Candida Infection Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. bioMérieux Candida Infection Testing Product Portfolio Table 62. bioMérieux Recent Development Table 63. Becton Dickinson Company Information Table 64. Becton Dickinson Business Overview Table 65. Becton Dickinson Candida Infection Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Becton Dickinson Candida Infection Testing Product Portfolio Table 67. Becton Dickinson Recent Development Table 68. Thermo Fisher Scientific Company Information Table 69. Thermo Fisher Scientific Business Overview Table 70. Thermo Fisher Scientific Candida Infection Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Thermo Fisher Scientific Candida Infection Testing Product Portfolio Table 72. Thermo Fisher Scientific Recent Development Table 73. Siemens Healthineers Company Information Table 74. Siemens Healthineers Business Overview Table 75. Siemens Healthineers Candida Infection Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Siemens Healthineers Candida Infection Testing Product Portfolio Table 77. Siemens Healthineers Recent Development Table 78. Bruker Company Information Table 79. Bruker Business Overview Table 80. Bruker Candida Infection Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Bruker Candida Infection Testing Product Portfolio Table 82. Bruker Recent Development Table 83. Danaher Company Information Table 84. Danaher Business Overview Table 85. Danaher Candida Infection Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Danaher Candida Infection Testing Product Portfolio Table 87. Danaher Recent Development Table 88. QuidelOrtho Company Information Table 89. QuidelOrtho Business Overview Table 90. QuidelOrtho Candida Infection Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. QuidelOrtho Candida Infection Testing Product Portfolio Table 92. QuidelOrtho Recent Development Table 93. Luminex Company Information Table 94. Luminex Business Overview Table 95. Luminex Candida Infection Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Luminex Candida Infection Testing Product Portfolio Table 97. Luminex Recent Development Table 98. Hologic Company Information Table 99. Hologic Business Overview Table 100. Hologic Candida Infection Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Hologic Candida Infection Testing Product Portfolio Table 102. Hologic Recent Development Table 103. Sysmex Company Information Table 104. Sysmex Business Overview Table 105. Sysmex Candida Infection Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Sysmex Candida Infection Testing Product Portfolio Table 107. Sysmex Recent Development Table 108. Bio‑Rad Laboratories Company Information Table 109. Bio‑Rad Laboratories Business Overview Table 110. Bio‑Rad Laboratories Candida Infection Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Bio‑Rad Laboratories Candida Infection Testing Product Portfolio Table 112. Bio‑Rad Laboratories Recent Development Table 113. Cepheid Company Information Table 114. Cepheid Business Overview Table 115. Cepheid Candida Infection Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Cepheid Candida Infection Testing Product Portfolio Table 117. Cepheid Recent Development Table 118. Qiagen Company Information Table 119. Qiagen Business Overview Table 120. Qiagen Candida Infection Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Qiagen Candida Infection Testing Product Portfolio Table 122. Qiagen Recent Development Table 123. ARUP Laboratories Company Information Table 124. ARUP Laboratories Business Overview Table 125. ARUP Laboratories Candida Infection Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. ARUP Laboratories Candida Infection Testing Product Portfolio Table 127. ARUP Laboratories Recent Development Table 128. Labcorp Company Information Table 129. Labcorp Business Overview Table 130. Labcorp Candida Infection Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Labcorp Candida Infection Testing Product Portfolio Table 132. Labcorp Recent Development Table 133. Quest Diagnostics Company Information Table 134. Quest Diagnostics Business Overview Table 135. Quest Diagnostics Candida Infection Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Quest Diagnostics Candida Infection Testing Product Portfolio Table 137. Quest Diagnostics Recent Development Table 138. Eurofins Scientific Company Information Table 139. Eurofins Scientific Business Overview Table 140. Eurofins Scientific Candida Infection Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. Eurofins Scientific Candida Infection Testing Product Portfolio Table 142. Eurofins Scientific Recent Development Table 143. Synlab Company Information Table 144. Synlab Business Overview Table 145. Synlab Candida Infection Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. Synlab Candida Infection Testing Product Portfolio Table 147. Synlab Recent Development Table 148. North America Candida Infection Testing Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. North America Candida Infection Testing Market Size by Country (2021-2026) & (US$ Million) Table 150. North America Candida Infection Testing Market Share by Country (2021-2026) Table 151. North America Candida Infection Testing Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. North America Candida Infection Testing Market Share Forecast by Country (2027-2032) Table 153. Europe Candida Infection Testing Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Europe Candida Infection Testing Market Size by Country (2021-2026) & (US$ Million) Table 155. Europe Candida Infection Testing Market Share by Country (2021-2026) Table 156. Europe Candida Infection Testing Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Europe Candida Infection Testing Market Share Forecast by Country (2027-2032) Table 158. Asia-Pacific Candida Infection Testing Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Asia-Pacific Candida Infection Testing Market Size by Country (2021-2026) & (US$ Million) Table 160. Asia-Pacific Candida Infection Testing Market Share by Country (2021-2026) Table 161. Asia-Pacific Candida Infection Testing Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Asia-Pacific Candida Infection Testing Market Share Forecast by Country (2027-2032) Table 163. Latin America Candida Infection Testing Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Latin America Candida Infection Testing Market Size by Country (2021-2026) & (US$ Million) Table 165. Latin America Candida Infection Testing Market Share by Country (2021-2026) Table 166. Latin America Candida Infection Testing Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Latin America Candida Infection Testing Market Share Forecast by Country (2027-2032) Table 168. Middle East & Africa Candida Infection Testing Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Middle East & Africa Candida Infection Testing Market Size by Country (2021-2026) & (US$ Million) Table 170. Middle East & Africa Candida Infection Testing Market Share by Country (2021-2026) Table 171. Middle East & Africa Candida Infection Testing Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Middle East & Africa Candida Infection Testing Market Share Forecast by Country (2027-2032) Table 173. Research Programs/Design for This Report Table 174. Authors List of This Report Table 175. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Candida Infection Testing Product Image Figure 3. Global Candida Infection Testing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Candida Infection Testing Market Size (2021-2032) & (US$ Million) Figure 5. Global Candida Infection Testing Market Share by Region: 2025 VS 2032 Figure 6. Global Candida Infection Testing Market Share by Region (2021-2032) Figure 7. North America Candida Infection Testing Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Candida Infection Testing Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Candida Infection Testing Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Candida Infection Testing Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Candida Infection Testing Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Traditional Culture Image Figure 13. Global Traditional Culture Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Molecular Biology Detection Image Figure 15. Global Molecular Biology Detection Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Candida Infection Testing Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Candida Infection Testing Market Share by Type 2025 VS 2032 Figure 18. North America Candida Infection Testing Market Size Share by Type (2021-2032) Figure 19. Europe Candida Infection Testing Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Candida Infection Testing Market Size Share by Type (2021-2032) Figure 21. Latin America Candida Infection Testing Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Candida Infection Testing Market Size Share by Type (2021-2032) Figure 23. Medical Image Figure 24. Global Medical Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Maternal and Child Health Image Figure 26. Global Maternal and Child Health Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Physical Examination Image Figure 28. Global Physical Examination Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Aesthetic Medicine Image Figure 30. Global Aesthetic Medicine Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Other Image Figure 32. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Global Candida Infection Testing Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Candida Infection Testing Market Share by Application 2025 VS 2032 Figure 35. North America Candida Infection Testing Market Size Share by Application (2021-2032) Figure 36. Europe Candida Infection Testing Market Size Share by Application (2021-2032) Figure 37. Asia-Pacific Candida Infection Testing Market Size Share by Application (2021-2032) Figure 38. Latin America Candida Infection Testing Market Size Share by Application (2021-2032) Figure 39. Middle East and Africa Candida Infection Testing Market Size Share by Application (2021-2032) Figure 40. Global Top 5 and 10 Candida Infection Testing Players Market Share by Revenue in 2025 Figure 41. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 42. North America Candida Infection Testing Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. North America Candida Infection Testing Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. North America Candida Infection Testing Market Share by Country (2021-2032) Figure 45. Europe Candida Infection Testing Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Candida Infection Testing Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Candida Infection Testing Market Share by Country (2021-2032) Figure 48. Asia-Pacific Candida Infection Testing Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Asia-Pacific Candida Infection Testing Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Asia-Pacific Candida Infection Testing Market Share by Country (2021-2032) Figure 51. Latin America Candida Infection Testing Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Latin America Candida Infection Testing Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Candida Infection Testing Market Share by Country (2021-2032) Figure 54. Middle East & Africa Candida Infection Testing Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Middle East & Africa Candida Infection Testing Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Middle East & Africa Candida Infection Testing Market Share by Country (2021-2032) Figure 57. Years Considered Figure 58. Research Process Figure 59. Key Executives Interviewed

Scope & coverage.

Types
  • Traditional Culture
  • Molecular Biology Detection
Applications
  • Medical
  • Maternal and Child Health
  • Physical Examination
  • Aesthetic Medicine
  • Other
Companies covered
  • Roche Diagnostics
  • Abbott Diagnostics
  • bioMérieux
  • Becton Dickinson
  • Thermo Fisher Scientific
  • Siemens Healthineers
  • Bruker
  • Danaher
  • QuidelOrtho
  • Luminex
  • Hologic
  • Sysmex
  • Bio‑Rad Laboratories
  • Cepheid
  • Qiagen
  • ARUP Laboratories
  • Labcorp
  • Quest Diagnostics
  • Eurofins Scientific
  • Synlab

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Candida Infection Testing Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Candida Infection Testing Market Size by Region (2021-2032)
  5. 1.4.1 Global Candida Infection Testing Market Size by Region (2021-2026)
  6. 1.4.2 Global Candida Infection Testing Market Size by Region (2027-2032)
  7. 1.5 Key Regions Candida Infection Testing Market Size (2021-2032)
  8. 1.5.1 North America Candida Infection Testing Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Candida Infection Testing Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Candida Infection Testing Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Candida Infection Testing Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Candida Infection Testing Market Size Growth Rate (2021-2032)
2 Candida Infection Testing Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Traditional Culture
  3. 2.1.2 Molecular Biology Detection
  4. 2.2 Global Candida Infection Testing Market Size by Type
  5. 2.2.1 Global Candida Infection Testing Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Candida Infection Testing Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Candida Infection Testing Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Candida Infection Testing Market Size by Regions
  9. 2.3.1 North America Candida Infection Testing Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Candida Infection Testing Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Candida Infection Testing Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Candida Infection Testing Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Candida Infection Testing Market Size Breakdown by Type (2021-2026)
3 Candida Infection Testing Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Medical
  3. 3.1.2 Maternal and Child Health
  4. 3.1.3 Physical Examination
  5. 3.1.4 Aesthetic Medicine
  6. 3.1.5 Other
  7. 3.2 Global Candida Infection Testing Market Size by Application
  8. 3.2.1 Global Candida Infection Testing Market Size Overview by Application (2021-2032)
  9. 3.2.2 Global Candida Infection Testing Historic Market Size Review by Application (2021-2026)
  10. 3.2.3 Global Candida Infection Testing Market Size Forecasted by Application (2027-2032)
  11. 3.3 Global Candida Infection Testing Market Size by Regions
  12. 3.3.1 North America Candida Infection Testing Market Size Breakdown by Application (2021-2026)
  13. 3.3.2 Europe Candida Infection Testing Market Size Breakdown by Application (2021-2026)
  14. 3.3.3 Asia-Pacific Candida Infection Testing Market Size Breakdown by Application (2021-2026)
  15. 3.3.4 South America Candida Infection Testing Market Size Breakdown by Application (2021-2026)
  16. 3.3.5 Middle East and Africa Candida Infection Testing Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Candida Infection Testing Industry Trends
  2. 4.2 Candida Infection Testing Industry Drivers
  3. 4.3 Candida Infection Testing Industry Opportunities and Challenges
  4. 4.4 Candida Infection Testing Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Candida Infection Testing Revenue (2021-2026)
  2. 5.2 Global Candida Infection Testing Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Candida Infection Testing Key Company Headquarters & Area Served
  4. 5.4 Global Candida Infection Testing Company, Product Type & Application
  5. 5.5 Global Candida Infection Testing Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Candida Infection Testing Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Candida Infection Testing Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Candida Infection Testing Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Roche Diagnostics
  2. 6.1.1 Roche Diagnostics Company Information
  3. 6.1.2 Roche Diagnostics Business Overview
  4. 6.1.3 Roche Diagnostics Candida Infection Testing Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Roche Diagnostics Candida Infection Testing Product Portfolio
  6. 6.1.5 Roche Diagnostics Recent Developments
  7. 6.2 Abbott Diagnostics
  8. 6.2.1 Abbott Diagnostics Company Information
  9. 6.2.2 Abbott Diagnostics Business Overview
  10. 6.2.3 Abbott Diagnostics Candida Infection Testing Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Abbott Diagnostics Candida Infection Testing Product Portfolio
  12. 6.2.5 Abbott Diagnostics Recent Developments
  13. 6.3 bioMérieux
  14. 6.3.1 bioMérieux Company Information
  15. 6.3.2 bioMérieux Business Overview
  16. 6.3.3 bioMérieux Candida Infection Testing Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 bioMérieux Candida Infection Testing Product Portfolio
  18. 6.3.5 bioMérieux Recent Developments
  19. 6.4 Becton Dickinson
  20. 6.4.1 Becton Dickinson Company Information
  21. 6.4.2 Becton Dickinson Business Overview
  22. 6.4.3 Becton Dickinson Candida Infection Testing Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Becton Dickinson Candida Infection Testing Product Portfolio
  24. 6.4.5 Becton Dickinson Recent Developments
  25. 6.5 Thermo Fisher Scientific
  26. 6.5.1 Thermo Fisher Scientific Company Information
  27. 6.5.2 Thermo Fisher Scientific Business Overview
  28. 6.5.3 Thermo Fisher Scientific Candida Infection Testing Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Thermo Fisher Scientific Candida Infection Testing Product Portfolio
  30. 6.5.5 Thermo Fisher Scientific Recent Developments
  31. 6.6 Siemens Healthineers
  32. 6.6.1 Siemens Healthineers Company Information
  33. 6.6.2 Siemens Healthineers Business Overview
  34. 6.6.3 Siemens Healthineers Candida Infection Testing Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Siemens Healthineers Candida Infection Testing Product Portfolio
  36. 6.6.5 Siemens Healthineers Recent Developments
  37. 6.7 Bruker
  38. 6.7.1 Bruker Company Information
  39. 6.7.2 Bruker Business Overview
  40. 6.7.3 Bruker Candida Infection Testing Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Bruker Candida Infection Testing Product Portfolio
  42. 6.7.5 Bruker Recent Developments
  43. 6.8 Danaher
  44. 6.8.1 Danaher Company Information
  45. 6.8.2 Danaher Business Overview
  46. 6.8.3 Danaher Candida Infection Testing Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Danaher Candida Infection Testing Product Portfolio
  48. 6.8.5 Danaher Recent Developments
  49. 6.9 QuidelOrtho
  50. 6.9.1 QuidelOrtho Company Information
  51. 6.9.2 QuidelOrtho Business Overview
  52. 6.9.3 QuidelOrtho Candida Infection Testing Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 QuidelOrtho Candida Infection Testing Product Portfolio
  54. 6.9.5 QuidelOrtho Recent Developments
  55. 6.10 Luminex
  56. 6.10.1 Luminex Company Information
  57. 6.10.2 Luminex Business Overview
  58. 6.10.3 Luminex Candida Infection Testing Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Luminex Candida Infection Testing Product Portfolio
  60. 6.10.5 Luminex Recent Developments
  61. 6.11 Hologic
  62. 6.11.1 Hologic Company Information
  63. 6.11.2 Hologic Business Overview
  64. 6.11.3 Hologic Candida Infection Testing Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Hologic Candida Infection Testing Product Portfolio
  66. 6.11.5 Hologic Recent Developments
  67. 6.12 Sysmex
  68. 6.12.1 Sysmex Company Information
  69. 6.12.2 Sysmex Business Overview
  70. 6.12.3 Sysmex Candida Infection Testing Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Sysmex Candida Infection Testing Product Portfolio
  72. 6.12.5 Sysmex Recent Developments
  73. 6.13 Bio‑Rad Laboratories
  74. 6.13.1 Bio‑Rad Laboratories Company Information
  75. 6.13.2 Bio‑Rad Laboratories Business Overview
  76. 6.13.3 Bio‑Rad Laboratories Candida Infection Testing Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Bio‑Rad Laboratories Candida Infection Testing Product Portfolio
  78. 6.13.5 Bio‑Rad Laboratories Recent Developments
  79. 6.14 Cepheid
  80. 6.14.1 Cepheid Company Information
  81. 6.14.2 Cepheid Business Overview
  82. 6.14.3 Cepheid Candida Infection Testing Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Cepheid Candida Infection Testing Product Portfolio
  84. 6.14.5 Cepheid Recent Developments
  85. 6.15 Qiagen
  86. 6.15.1 Qiagen Company Information
  87. 6.15.2 Qiagen Business Overview
  88. 6.15.3 Qiagen Candida Infection Testing Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Qiagen Candida Infection Testing Product Portfolio
  90. 6.15.5 Qiagen Recent Developments
  91. 6.16 ARUP Laboratories
  92. 6.16.1 ARUP Laboratories Company Information
  93. 6.16.2 ARUP Laboratories Business Overview
  94. 6.16.3 ARUP Laboratories Candida Infection Testing Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 ARUP Laboratories Candida Infection Testing Product Portfolio
  96. 6.16.5 ARUP Laboratories Recent Developments
  97. 6.17 Labcorp
  98. 6.17.1 Labcorp Company Information
  99. 6.17.2 Labcorp Business Overview
  100. 6.17.3 Labcorp Candida Infection Testing Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Labcorp Candida Infection Testing Product Portfolio
  102. 6.17.5 Labcorp Recent Developments
  103. 6.18 Quest Diagnostics
  104. 6.18.1 Quest Diagnostics Company Information
  105. 6.18.2 Quest Diagnostics Business Overview
  106. 6.18.3 Quest Diagnostics Candida Infection Testing Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Quest Diagnostics Candida Infection Testing Product Portfolio
  108. 6.18.5 Quest Diagnostics Recent Developments
  109. 6.19 Eurofins Scientific
  110. 6.19.1 Eurofins Scientific Company Information
  111. 6.19.2 Eurofins Scientific Business Overview
  112. 6.19.3 Eurofins Scientific Candida Infection Testing Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 Eurofins Scientific Candida Infection Testing Product Portfolio
  114. 6.19.5 Eurofins Scientific Recent Developments
  115. 6.20 Synlab
  116. 6.20.1 Synlab Company Information
  117. 6.20.2 Synlab Business Overview
  118. 6.20.3 Synlab Candida Infection Testing Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 Synlab Candida Infection Testing Product Portfolio
  120. 6.20.5 Synlab Recent Developments
7 North America
  1. 7.1 North America Candida Infection Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Candida Infection Testing Market Size by Country (2021-2026)
  3. 7.3 North America Candida Infection Testing Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Candida Infection Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Candida Infection Testing Market Size by Country (2021-2026)
  3. 8.3 Europe Candida Infection Testing Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Candida Infection Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Candida Infection Testing Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Candida Infection Testing Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Candida Infection Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Candida Infection Testing Market Size by Country (2021-2026)
  3. 10.3 South America Candida Infection Testing Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Candida Infection Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Candida Infection Testing Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Candida Infection Testing Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst